Feb 19, 2026,
Markets,
Feb 16, 2026
For half a century, the U.S. didn't approve a single new license to manufacture advanced nuclear fuel. That changed on Feb. 13, when TRISO-X — a subsidiary of Amazon.com Inc (NASDAQ:AMZN)-backed X-Energy — received federal approval to produce next-generation reactor…
Technology
For most of the period following the 2008–09 financial crisis, markets repeated the same mantra: own growth, own tech, ignore the rest. Capital-light business models dominated. Software scaled. Margins expanded. With interest rates pinned near zero and liquidity abundant, the…
Feb 12, 2026
Keep reading
Ad
If you can’t decide whether to get the 2-in-1 Windows tablet hybrid, traditional laptop, or desktop, we’re here to help.
News
Gold.com (NYSE:GOLD) has outperformed the market over the past 5 years by 3.75% on an annualized basis producing an average annual return of 15.78%. Currently, Gold.com has a market capitalization of $1.58 billion. Buying $1000 In GOLD: If an investor…
Feb 11, 2026
Keep reading
Markets
Deep-pocketed investors have adopted a bearish approach towards Alphabet (NASDAQ:GOOGL), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a…
Feb 10, 2026
Keep reading
Ad
If you can’t decide whether to get the 2-in-1 Windows tablet hybrid, traditional laptop, or desktop, we’re here to help.
Are You Taking One of These 9 “Memory Erasing” Prescriptions? [ad]
You may think your memory loss is just a sign of getting older, but one of these 9 drugs could actually be damaging your brain... These 9 prescription drugs have now been linked to Alzheimer's disease diagnoses. If you're over the age of 60, and you're taking even 1 of these 9 drugs, your brain could be at risk. Click here to learn more.